188 related articles for article (PubMed ID: 10329597)
1. Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease: lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease.
Izban KF; Wrone-Smith T; Hsi ED; Schnitzer B; Quevedo ME; Alkan S
Am J Pathol; 1999 May; 154(5):1439-47. PubMed ID: 10329597
[TBL] [Abstract][Full Text] [Related]
2. Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Huang Q; Qin JZ; Martinez RL; Schnitzer B; Ni H; Nickoloff BJ; Alkan S
Mod Pathol; 2001 Apr; 14(4):297-310. PubMed ID: 11301346
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of interleukin-1beta-converting enzyme/Ced-3 family protease, CPP32/Yama/Caspase-3, in Hodgkin's disease.
Chhanabhai M; Krajewski S; Krajewska M; Wang HG; Reed JC; Gascoyne RD
Blood; 1997 Sep; 90(6):2451-5. PubMed ID: 9310497
[TBL] [Abstract][Full Text] [Related]
4. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S
Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869
[TBL] [Abstract][Full Text] [Related]
5. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis.
Hasegawa J; Kamada S; Kamiike W; Shimizu S; Imazu T; Matsuda H; Tsujimoto Y
Cancer Res; 1996 Apr; 56(8):1713-8. PubMed ID: 8620480
[TBL] [Abstract][Full Text] [Related]
6. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
Kamel OW; Gelb AB; Shibuya RB; Warnke RA
Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
[TBL] [Abstract][Full Text] [Related]
7. Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status.
Flavell JR; Baumforth KR; Williams DM; Lukesova M; Madarova J; Noskova V; Prochazkova J; Lowe D; Kolar Z; Murray PG; Nelson PN
Mol Pathol; 2000 Jun; 53(3):145-9. PubMed ID: 10897334
[TBL] [Abstract][Full Text] [Related]
8. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes.
Krajewski S; Gascoyne RD; Zapata JM; Krajewska M; Kitada S; Chhanabhai M; Horsman D; Berean K; Piro LD; Fugier-Vivier I; Liu YJ; Wang HG; Reed JC
Blood; 1997 May; 89(10):3817-25. PubMed ID: 9160689
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of nodular lymphocyte predominance Hodgkin's disease and Hodgkin's disease of the usual type.
Gelb AB; Dorfman RF; Warnke RA
Am J Surg Pathol; 1993 Apr; 17(4):364-74. PubMed ID: 8494105
[TBL] [Abstract][Full Text] [Related]
10. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
Timens W; Visser L; Poppema S
Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
[TBL] [Abstract][Full Text] [Related]
11. Cysteine protease CPP32, but not Ich1-L, is expressed in germinal center B cells and their neoplastic counterparts.
Xerri L; Devilard E; Ayello C; Brousset P; Reed JC; Emile JF; Hassoun J; Parmentier S; Birg F
Hum Pathol; 1997 Aug; 28(8):912-21. PubMed ID: 9269827
[TBL] [Abstract][Full Text] [Related]
12. Tetrapeptide DEVD-aldehyde or YVAD-chloromethylketone inhibits Fas/Apo-1(CD95)-mediated apoptosis in renal-cell-cancer cells.
Tomita Y; Kawasaki T; Bilim V; Takeda M; Takahashi K
Int J Cancer; 1996 Sep; 68(1):132-5. PubMed ID: 8895553
[TBL] [Abstract][Full Text] [Related]
13. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases).
Los M; Herr I; Friesen C; Fulda S; Schulze-Osthoff K; Debatin KM
Blood; 1997 Oct; 90(8):3118-29. PubMed ID: 9376593
[TBL] [Abstract][Full Text] [Related]
14. Ceramide-induced apoptosis in fas-resistant Hodgkin's disease cell lines is caspase independent.
Metkar SS; Anand M; Manna PP; Naresh KN; Nadkarni JJ
Exp Cell Res; 2000 Feb; 255(1):18-29. PubMed ID: 10666330
[TBL] [Abstract][Full Text] [Related]
15. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases.
Jones RA; Johnson VL; Buck NR; Dobrota M; Hinton RH; Chow SC; Kass GE
Hepatology; 1998 Jun; 27(6):1632-42. PubMed ID: 9620337
[TBL] [Abstract][Full Text] [Related]
16. [Hodgkin's nodular paragranuloma (nodular Hodgkin's disease, with lymphocytic predominance): apropos of 29 cases].
Molina T; Diebold J
Bull Cancer; 1987; 74(4):463-72. PubMed ID: 3663967
[TBL] [Abstract][Full Text] [Related]
17. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis.
Enari M; Talanian RV; Wong WW; Nagata S
Nature; 1996 Apr; 380(6576):723-6. PubMed ID: 8614469
[TBL] [Abstract][Full Text] [Related]
18. Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line.
Irisarri M; Plumas J; Bonnefoix T; Jacob MC; Roucard C; Pasquier MA; Sotto JJ; Lajmanovich A
Leukemia; 2000 Dec; 14(12):2149-58. PubMed ID: 11187905
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of CD30 remains negative in nodular lymphocyte-predominant Hodgkin's disease using enhanced antigen retrieval.
Roberts C; Jack F; Angus B; Reid A; Thompson WD
Histopathology; 2002 Feb; 40(2):166-70. PubMed ID: 11952861
[TBL] [Abstract][Full Text] [Related]
20. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
